Setanaxib

N/A

Report date: 2024/03/07 13:13:11
NME

Base Information

Drug NameSetanaxib
Drug Alias NameGKT-831GKT-137831
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase 4 inhibitorsNADPH oxidase 1 inhibitors
TargetsNADPH oxidase 4NADPH oxidase 1
Therapy Area/IndicationsDiabetic NephropathiesNephritis, HereditaryIdiopathic Pulmonary Fibrosis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[18] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenkyotex Sa
China Registration ClassN/A

Develop Information

Active CompaniesCalliditas Therapeutics AbUniversity Of Alabama At Birmingham
Inactive CompaniesN/A
Active IndicationsNephritis, HereditaryIdiopathic Pulmonary FibrosisLiver Cirrhosis +[5] 
Inactive IndicationsDiabetic NephropathiesLiver Cirrhosis, Biliary

Other Information

ATC CodeN/A
Related LinksN/A